高级检索

    2周或3周CHOP加或不加依托泊苷治疗无不良预后因素(LDH正常)年轻侵袭性淋巴瘤NHL-B1临床试验结果

    Two-Weekly or Three-Weekly CHOP Chemotherapy with or without Etoposide for the Treatment of Young Patients with Good-Prognosis (Normal LDH) Aggressive Lymphomas: Results of the NHL-B1 Trial of the DSHNHL

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回